Clinical Study of UTD1 Injection in Combination With Capecitabine in Patients With Advanced and Metastatic Breast Cancer

NCT02253459 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

405

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: UTD1 Injection plus capecitabine
DRUG: Capecitabine

Sponsor

Beijing Biostar Pharmaceuticals Co., Ltd.